| Literature DB >> 36080451 |
Yue Zhang1, Meiran Wang1, Thiphavanh Silipunyo1,2, Haizhu Huang1, Qingchun Yin3, Bingjun Han1, Mingyue Wang1.
Abstract
Triflumezopyrim, a novel mesoionic insecticide used to control planthoppers, is a potential substitute for imidacloprid. In this study, triflumezopyrim and imidacloprid residues in rice were determined using a quick, easy, cheap, effective, rugged, and safe procedure combined with ultra-high-performance liquid chromatography-tandem mass spectrometry. The limit of quantification of both triflumezopyrim and imidacloprid was 0.01 mg kg-1, and the average recovery values were 94-104% and 91-106%, with relative standard deviations (RSDs) of 1.1-1.4% and 2.1-3.4% (n = 5), respectively. The consumer protection level was assessed by calculating the theoretical maximum daily intake using the reported maximum residue limits of triflumezopyrim and imidacloprid. The established method was successfully applied to 200 commercial rice samples collected from four provinces in China, and their potential public health risks were assessed using triflumezopyrim and imidacloprid residues. The risk associated with triflumezopyrim and imidacloprid dietary intake was assessed by calculating the national estimated short-term intake and the acute reference dose percentage (%ARfD). The results show that the theoretical maximum daily intake (NEDI) values of triflumezopyrim and imidacloprid in different age and gender groups were 0.219-0.543 and 0.377-0.935 μg kg-1 d-1 bw, and the risk quotient (RQ) values were 0.188-0.467% and 0.365-0.906%, respectively. The acute reference dose (%ARfD) of triflumezopyrim and imidaclopridin ranged from 0.615 to 0.998% and from 0.481 to 0.780%, respectively.Entities:
Keywords: imidacloprid; rice; risk assessment; triflumezopyrim
Mesh:
Substances:
Year: 2022 PMID: 36080451 PMCID: PMC9458175 DOI: 10.3390/molecules27175685
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical structure of triflumezopyrim (a) and imidacloprid (b).
Figure 2Effect of different extraction methods with and without water on recovery. The letters (a and b) indicate a significant difference at the 1% level.
Figure 3Effect of different purification sorbents on recovery. The letters (a and b) indicate a significant difference at the 1% level.
Average recoveries and RSDs at three spiked levels.
| Compounds | Spiking Levels/(mg/kg) | Average Recovery/% | RSD/% | LOQ/(mg/kg) |
|---|---|---|---|---|
| imidacloprid | 0.01 | 106 | 2.1 | 0.01 |
| 0.10 | 91 | 2.6 | ||
| 0.20 | 97 | 3.4 | ||
| triflumezopyrim | 0.01 | 104 | 1.1 | 0.01 |
| 0.10 | 101 | 1.4 | ||
| 0.20 | 94 | 1.4 |
Method validation parameters.
| Compounds | Matrix | Regression Equation | Correlation Coefficients | ME/% |
|---|---|---|---|---|
| imidacloprid | solvent | y = 1,963,648x − 3902 | 0.9999 | - |
| rice | y = 1,176,517x − 449 | 0.9980 | −37.3 | |
| triflumezopyrim | solvent | y = 1,617,540x + 211 | 0.9998 | - |
| rice | y = 5,291,693x − 1059 | 0.9992 | 224.2 |
Figure 4Typical LC-MS/MS chromatograms of triflumezopyrim and imidacloprid. (a) blank sample, (b) standard, (c) recovery at 0.01 mg/kg, (d) recovery at 0.1 mg/kg, (e) recovery at 0.2 mg/kg.
Risk assessment data according to the JMPR report.
| Compounds | ADI, mg/kg bw | ARfD, mg/kg bw | STMR, mg/kg | HR, mg/kg |
|---|---|---|---|---|
| imidacloprid | 0.06 | 0.4 | 0.05 | 0.05 |
| triflumezopyrim | 0.2 | 1 | 0.086 | 0.16 |
Figure 5Residues of triflumezopyrim and imidacloprid in positive rice samples.
Long-term intake assessment at the different age groups.
| Age | Gender | bw/(kg) | Fi/(g d−1) | NEDI/(μg kg−1 d−1 bw) | RQ/(%) | ||
|---|---|---|---|---|---|---|---|
| Imidacloprid | Triflumezopyrim | Imidacloprid | Triflumezopyrim | ||||
| 2–3 | Male | 13.2 | 135.5 | 0.883 | 0.513 | 0.855 | 0.441 |
| Female | 12.3 | 133.7 | 0.935 | 0.543 | 0.906 | 0.467 | |
| 4–6 | Male | 16.8 | 179.7 | 0.920 | 0.535 | 0.891 | 0.460 |
| Female | 16.2 | 159.5 | 0.847 | 0.492 | 0.820 | 0.423 | |
| 7–10 | Male | 22.9 | 230.8 | 0.867 | 0.504 | 0.840 | 0.433 |
| Female | 21.7 | 212.0 | 0.840 | 0.488 | 0.814 | 0.420 | |
| 11–13 | Male | 34.1 | 266.2 | 0.671 | 0.390 | 0.651 | 0.336 |
| Female | 34.0 | 238.4 | 0.603 | 0.351 | 0.584 | 0.302 | |
| 14–17 | Male | 46.7 | 308.7 | 0.568 | 0.331 | 0.551 | 0.284 |
| Female | 45.2 | 240.7 | 0.458 | 0.266 | 0.444 | 0.229 | |
| 18–29 | Male | 58.4 | 309.6 | 0.456 | 0.265 | 0.442 | 0.228 |
| Female | 52.1 | 260.9 | 0.431 | 0.250 | 0.417 | 0.215 | |
| 30–44 | Male | 64.9 | 316.2 | 0.419 | 0.244 | 0.406 | 0.210 |
| Female | 55.7 | 278.6 | 0.430 | 0.250 | 0.417 | 0.215 | |
| 45–59 | Male | 63.1 | 314.9 | 0.429 | 0.250 | 0.416 | 0.215 |
| Female | 57.0 | 272.8 | 0.412 | 0.239 | 0.399 | 0.206 | |
| 60–69 | Male | 61.5 | 274.0 | 0.383 | 0.223 | 0.371 | 0.192 |
| Female | 54.3 | 242.9 | 0.385 | 0.224 | 0.373 | 0.192 | |
| ≥70 | Male | 58.5 | 258.3 | 0.380 | 0.221 | 0.368 | 0.190 |
| Female | 51.0 | 223.5 | 0.377 | 0.219 | 0.365 | 0.188 | |
Figure 6Risk quotient (RQ) of triflumezopyrim and imidacloprid in rice for the different ages and sexes.
Short-term intake assessment of triflumezopyrim and imidacloprid.
| Age | bw/(kg) | LP/(g d−1) | Ue/(g) | NESTI/(μg kg−1 d−1, bw) | %ARfD/(%) | ||
|---|---|---|---|---|---|---|---|
| Imidacloprid | Triflumezopyrim | Imidacloprid | Triflumezopyrim | ||||
| 1–6 | 16.1 | 1004.28 | <25 | 3.119 | 9.980 | 0.780 | 0.998 |
| General population | 53.2 | 2046.23 | <25 | 1.923 | 6.154 | 0.481 | 0.615 |
Figure 7%ARfD of triflumezopyrim and imidacloprid in rice for different ages. The letters (a, b, c and d) indicate a significant difference at the 1% level.
MS/MS parameters for the analysis.
| Compounds | Ions | Declustering Potential/V | Collision Energy/V |
|---|---|---|---|
| imidacloprid | 256.2/175 * | 69 | 25.2 |
| triflumezopyrim | 399.1/278.1 * | 120 | 40 |
* Quantitative ion.